4.7 Article

Local and systemic factors and implantation: what is the evidence?

Journal

FERTILITY AND STERILITY
Volume 105, Issue 4, Pages 873-884

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2016.02.018

Keywords

Endometrium; implantation; immune factors; IVF; thyroid; vitamin D

Funding

  1. National Institutes of Health [R01 HD067721, R01 HD057873]

Ask authors/readers for more resources

Significant progress has been made in the understanding of embryonic competence and endometrial receptivity since the inception of assisted reproductive technology. The endometrium is a highly dynamic tissue that plays a crucial role in the establishment and maintenance of normal pregnancy. In response to steroid sex hormones, the endometrium undergoes marked changes during the menstrual cycle that are critical for acceptance of the nascent embryo. There is also a wide body of literature on systemic factors that impact assisted reproductive technology outcomes. Patient prognosis is impacted by an array of factors that tip the scales in her favor or against success. Recognizing the local and systemic factors will allow clinicians to better understand and optimize the maternal environment at the time of implantation. This review will address the current literature on endometrial and systemic factors related to impaired implantation and highlight recent advances in this area of reproductive medicine. (C) 2016 by American Society for Reproductive Medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Obstetrics & Gynecology

Maternal microbiome and pregnancy outcomes

Chelsea Fox, Kacey Eichelberger

FERTILITY AND STERILITY (2015)

Article Obstetrics & Gynecology

Immune-inflammation gene signatures in endometriosis patients

Soo Hyun Ahn, Kasra Khalaj, Steven L. Young, Bruce A. Lessey, Madhuri Koti, Chandrakant Tayade

FERTILITY AND STERILITY (2016)

Article Obstetrics & Gynecology

Luteal phase HCG support for unexplained recurrent pregnancy loss - a low hanging fruit?

Chelsea Fox, Denise Azores-Gococo, Linda Swart, Kristin Holoch, Ricardo F. Savaris, Creighton E. Likes, Paul B. Miller, David A. Forstein, Bruce A. Lessey

REPRODUCTIVE BIOMEDICINE ONLINE (2017)

Article Genetics & Heredity

Medical or surgical treatment before embryo transfer improves outcomes in women with abnormal endometrial BCL6 expression

Creighton E. Likes, Leah J. Cooper, Jessica Efird, David A. Forstein, Paul B. Miller, Ricardo Savaris, Bruce A. Lessey

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2019)

Article Genetics & Heredity

FOXO1 regulates uterine epithelial integrity and progesterone receptor expression critical for embryo implantation

Yasmin M. Vasquez, Xiaoqiu Wang, Margeaux Wetendorf, Heather L. Franco, Qianxing Mo, Tianyuan Wang, Rainer B. Lanz, Steven L. Young, Bruce A. Lessey, Thomas E. Spencer, John P. Lydon, Francesco J. DeMayo

PLOS GENETICS (2018)

Article Endocrinology & Metabolism

Role of SIRT1 and Progesterone Resistance in Normal and Abnormal Endometrium

Tae Hoon Kim, Steven L. Young, Tsutomu Sasaki, Jeffrey L. Deaton, David P. Schammel, Wilder Alberto Palomino, Jae-Wook Jeong, Bruce A. Lessey

Summary: The study revealed that SIRT1 expression in the endometrium is associated with progesterone resistance and normal endometrial function, while aberrant SIRT1 expression may contribute to progesterone resistance and the pathophysiology of endometriosis. SIRT1 serves as a novel and targetable protein for the diagnosis and treatment of endometriosis and infertility associated with this disease.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Medicine, Research & Experimental

IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis

Jessica E. Miller, Harshavardhan Lingegowda, Lindsey K. Symons, Olga Bougie, Steven L. Young, Bruce A. Lessey, Madhuri Koti, Chandrakant Tayade

Summary: The study found that IL-33 contributes to the expansion of ILC2s in both humans and murine models, regulating the microenvironment of endometriosis lesions, and driving severe endometriosis symptoms such as inflammation, lesion proliferation, and fibrosis. IL-33 neutralization shows promise as a potential novel therapeutic avenue for treating the debilitating symptoms of endometriosis.

JCI INSIGHT (2021)

Letter Obstetrics & Gynecology

B-cell lymphoma 6 (BCL6) testing before in vitro fertilization as a predictor of failure

Ricardo F. Savaris, Bruce A. Lessey

FERTILITY AND STERILITY (2022)

Article Obstetrics & Gynecology

Unexplained recurrent pregnancy loss and unexplained infertility: twins in disguise

Chelsea W. Fox, Ricardo F. Savaris, Jae-Wook Jeong, Tae Hoon Kim, Paul B. Miller, Creighton E. Likes, David P. Schammel, Steven L. Young, Bruce A. Lessey

HUMAN REPRODUCTION OPEN (2020)

Article Endocrinology & Metabolism

Inflammatory Stimuli Trigger Increased Androgen Production and Shifts in Gene Expression in Theca-Interstitial Cells

Chelsea W. Fox, Lingzhi Zhang, Abhishek Sohni, Manuel Doblado, Miles F. Wilkinson, R. Jeffrey Chang, Antoni J. Duleba

ENDOCRINOLOGY (2019)

Article Medicine, Research & Experimental

Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature

Kasra Khalaj, Jessica E. Miller, Harshavardhan Lingegowda, Asgerally T. Fazleabas, Steven L. Young, Bruce A. Lessey, Madhuri Koti, Chandrakant Tayade

JCI INSIGHT (2019)

No Data Available